Key facts
- Enspire DBS Therapy’s last known valuation is $32.5M (Jan 2026).
- It has raised $33.0M; the latest was Later Stage VC ($10.3M) in Jan 2026.
- Notable investors include JobsOhio Ventures, Cleveland Clinic Ventures, Genesys Capital, Guide Medical Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Enspire DBS Therapy
- ·The full record, as it builds
Funding rounds
No funding rounds for Enspire DBS Therapy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enspire DBS Therapy
Operator of a brain stimulation healthcare company intended to aid patients in restoring arm motor function. The company specializes in revitalizing stroke recovery alongside physical rehabilitation by using natural pathways to mediate the effects of physical therapy, enabling patients to have access to accelerated post-stroke recovery.
- Sector
- Healthcare
- HQ
- Cleveland, OH, United States
- Founded
- 2010
- Employees
- 10
- Website
- enspiredbs.com/
- Ownership
- Privately Held (backing)
Enspire DBS Therapy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enspire DBS Therapy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enspire DBS Therapy in its N-PORT filings yet. We sweep new filings monthly.